FDA shortens timing of Moderna booster to 5 months

vaccine
Credit: Pixabay/CC0 Public Domain

U.S. regulators on Friday shortened the time that people who received Moderna's COVID-19 vaccine have to wait for a booster—to five months rather than six.

The two-dose Moderna vaccine is open to Americans 18 and older. The Food and Drug Administration's decision Friday means Moderna recipients are eligible for a booster after at least five months have passed since their last shot. The Centers for Disease Control and Prevention agreed.

That's in line with new recommendations for recipients of the Pfizer vaccine. Initial Pfizer vaccinations are open to anyone 5 or older. But only Pfizer recipients 12 and older are eligible for boosters, and earlier this week U.S. health authorities said they can get one five months after their last shot.

In a statement, FDA vaccine chief Dr. Peter Marks called vaccination "our against COVID-19" and said a shortened wait for a booster may help as the country battles a surge of the highly contagious omicron variant.

A booster after receiving the single-dose Johnson & Johnson vaccine already is urged two months later.


Explore further

US advisers debate Pfizer boosters for younger teens

© 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Citation: FDA shortens timing of Moderna booster to 5 months (2022, January 7) retrieved 19 May 2022 from https://medicalxpress.com/news/2022-01-fda-shortens-moderna-booster-months.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
23 shares

Feedback to editors